https://orcid.org/0000-0002-4501-6917
Abstract
Unique among coagulation factors, the coagulation factor XI (FXI) arose through a duplication of the gene KLKB1, which encodes plasma prekallikrein. This evolutionary origin sets FXI apart structurally because it is a homodimer with 2 identical subunits composed of 4 apple and 1 catalytic domain. Each domain exhibits unique affinities for binding partners within the coagulation cascade, regulating the conversion of FXI to a serine protease as well as the selectivity of substrates cleaved by the active form of FXI. Beyond serving as the molecular nexus for the extrinsic and contact pathways to propagate thrombin generation by way of activating FIX, the function of FXI extends to contribute to barrier function, platelet activation, inflammation, and the immune response. Herein, we critically review the current understanding of the molecular biology of FXI, touching on some functional consequences at the cell, tissue, and organ level. We conclude each section by highlighting the DNA mutations within each domain that present as FXI deficiency. Together, a narrative review of the structure-function of the domains of FXI is imperative to understand the etiology of hemophilia C as well as to identify regions of FXI to safely inhibit the pathological function of activation or activity of FXI without compromising the physiologic role of FXI.
References
1.
Quelin
F
, Mathonnet
F
, Potentini-Esnault
C
, et al. Identification of five novel mutations in the factor XI gene (F11) of patients with factor XI deficiency
. Blood Coagul Fibrinolysis
. 2006
;17
(1
):69
-73
.2.
Rosenthal
RL
, Dreskin
OH
, Rosenthal
N
. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor
. Proc Soc Exp Biol Med
. 1953
;82
(1
):171
-174
.3.
Jayakrishnan
T
, Shah
D
, Mewawalla
P
. A case report with updates on diagnosis and management of a rare bleeding disorder
. J Hematol
. 2019
;8
(3
):144
-147
.4.
Joseph
K
, Kaplan
AP
. Formation of bradykinin: a major contributor to the innate inflammatory response
. Adv Immunol
. 2005
;86
:159
-208
.5.
Mohammed
BM
, Matafonov
A
, Ivanov
I
, et al. An update on factor XI structure and function
. Thromb Res
. 2018
;161
:94
-105
.6.
Emsley
J
, McEwan
PA
, Gailani
D
. Structure and function of factor XI
. Blood
. 2010
;115
(13
):2569
-2577
.7.
Shearin
S
, Venkateswarlu
D
. Structural insights into the activation of blood coagulation factor XI zymogen by thrombin: a computational molecular dynamics study
. Biophys Chem
. 2022
;281
:106737
.8.
Papagrigoriou
E
, McEwan
PA
, Walsh
PN
, Emsley
J
. Crystal structure of the factor XI zymogen reveals a pathway for transactivation
. Nat Struct Mol Biol
. 2006
;13
(6
):557
-558
.9.
Gailani
D
, Smith
SB
. Structural and functional features of factor XI
. J Thromb Haemost
. 2009
;7
(suppl 1
):75
-78
.10.
Samuel
D
, Cheng
H
, Riley
PW
, et al. Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation
. Proc Natl Acad Sci U S A
. 2007
;104
(40
):15693
-15698
.11.
Lira
AL
, Kohs
TCL
, Moellmer
SA
, Shatzel
JJ
, McCarty
OJT
, Puy
C
. Substrates, cofactors, and cellular targets of coagulation factor XIa
. Semin Thromb Hemost
. Published online 20 March 2023
https://doi.org/10.1055/s-0043-1764469.12.
Renne
T
, Gailani
D
, Meijers
JC
, Muller-Esterl
W
. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein
. J Biol Chem
. 2002
;277
(7
):4892
-4899
.13.
Kravtsov
DV
, Matafonov
A
, Tucker
EI
, et al. Factor XI contributes to thrombin generation in the absence of factor XII
. Blood
. 2009
;114
(2
):452
-458
.14.
Baglia
FA
, Walsh
PN
. A binding site for thrombin in the apple 1 domain of factor XI
. J Biol Chem
. 1996
;271
(7
):3652
-3658
.15.
Baglia
FA
, Jameson
BA
, Walsh
PN
. Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86
. J Biol Chem
. 1990
;265
(7
):4149
-4154
.16.
Baglia
FA
, Jameson
BA
, Walsh
PN
. Fine mapping of the high molecular weight kininogen binding site on blood coagulation factor XI through the use of rationally designed synthetic analogs
. J Biol Chem
. 1992
;267
(6
):4247
-4252
.17.
Wong
SS
, Ostergaard
S
, Hall
G
, et al. A novel DFP tripeptide motif interacts with the coagulation factor XI apple 2 domain
. Blood
. 2016
;127
(23
):2915
-2923
.18.
Li
C
, Barroeta
AB
, Wong
SS
, et al. Structures of factor XI and prekallikrein bound to domain 6 of high molecular weight kininogen reveals alternate domain 6 conformations and exosites
. J Thromb Haemost
. 2023
;21
(9
):2378
-2389
.19.
Cheng
Q
, Tucker
EI
, Pine
MS
, et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
. Blood
. 2010
;116
(19
):3981
-3989
.20.
Sun
MF
, Zhao
M
, Gailani
D
. Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX
. J Biol Chem
. 1999
;274
(51
):36373
-36378
.21.
Ho
DH
, Baglia
FA
, Walsh
PN
. Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain
. Biochemistry
. 2000
;39
(2
):316
-323
.22.
Baglia
FA
, Gailani
D
, Lopez
JA
, Walsh
PN
. Identification of a binding site for glycoprotein Ibalpha in the Apple 3 domain of factor XI
. J Biol Chem
. 2004
;279
(44
):45470
-45476
.23.
Baglia
FA
, Shrimpton
CN
, Emsley
J
, et al. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet
. J Biol Chem
. 2004
;279
(47
):49323
-49329
.24.
Bar Barroeta
A
, Marquart
JA
, Bakhtiari
K
, Meijer
AB
, Urbanus
RT
, Meijers
JCM
. Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen
. J Thromb Haemost
. 2022
;20
(11
):2538
-2549
.25.
Matafonov
A
, Cheng
Q
, Geng
Y
, et al. Evidence for factor IX-independent roles for factor XIa in blood coagulation
. J Thromb Haemost
. 2013
;11
(12
):2118
-2127
.26.
Ho
DH
, Badellino
K
, Baglia
FA
, Walsh
PN
. A binding site for heparin in the apple 3 domain of factor XI
. J Biol Chem
. 1998
;273
(26
):16382
-16390
.27.
Zhao
M
, Abdel-Razek
T
, Sun
MF
, Gailani
D
. Characterization of a heparin binding site on the heavy chain of factor XI
. J Biol Chem
. 1998
;273
(47
):31153
-31159
.28.
Morla
S
, Deguchi
H
, Zilberman-Rudenko
J
, et al. Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation
. J Biol Chem
. 2022
;298
(2
):101567
.29.
Puy
C
, Tucker
EI
, Wong
ZC
, et al. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates
. J Thromb Haemost
. 2013
;11
(7
):1341
-1352
.30.
Wu
W
, Sinha
D
, Shikov
S
, et al. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa
. J Biol Chem
. 2008
;283
(27
):18655
-18664
.31.
Geng
Y
, Verhamme
IM
, Smith
SB
, et al. The dimeric structure of factor XI and zymogen activation
. Blood
. 2013
;121
(19
):3962
-3969
.32.
Yang
L
, Sun
MF
, Gailani
D
, Rezaie
AR
. Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor
. Biochemistry
. 2009
;48
(7
):1517
-1524
.33.
Rezaie
AR
, Sun
MF
, Gailani
D
. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity
. Biochemistry
. 2006
;45
(31
):9427
-9433
.34.
Gailani
D
, Broze
GJ
. Factor XI activation in a revised model of blood coagulation
. Science
. 1991
;253
(5022
):909
-912
.35.
Naito
K
, Fujikawa
K
. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces
. J Biol Chem
. 1991
;266
(12
):7353
-7358
.36.
Lakshmanan
HHS
, Estonilo
A
, Reitsma
SE
, et al. Revised model of the tissue factor pathway of thrombin generation: role of the feedback activation of FXI
. J Thromb Haemost
. 2022
;20
(6
):1350
-1363
.37.
Factor XI Gene (F11) Variant Database
. Accessed 20 September 2023. https://www.factorxi.org/.38.
Harris
VA
, Lin
W
, Perkins
SJ
. Analysis of 272 genetic variants in the upgraded interactive FXI web database reveals new insights into FXI deficiency
. TH Open
. 2021
;5
(4
):e543
-e556
.39.
Zivelin
A
, Bauduer
F
, Ducout
L
, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene
. Blood
. 2002
;99
(7
):2448
-2454
.40.
Esteban
J
, de la Morena-Barrio
ME
, Salloum-Asfar
S
, et al. High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: results from the Yecla study
. Haemophilia
. 2017
;23
(6
):e488
-e496
.41.
Hill
M
, McLeod
F
, Franks
H
, Gordon
B
, Dolan
G
. Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction-based test to define a whole gene deletion
. Br J Haematol
. 2005
;129
(6
):825
-829
.42.
Shao
Y
, Cao
Y
, Lu
Y
, et al. Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China
. Blood Cells Mol Dis
. 2016
;58
:29
-34
.43.
Zucker
M
, Zivelin
A
, Landau
M
, et al. Characterization of seven novel mutations causing factor XI deficiency
. Haematologica
. 2007
;92
(10
):1375
-1380
.44.
gnomAD browser
. Accessed 20 September 2023. https://gnomad.broadinstitute.org/gene/ENSG00000088926?dataset=gnomad_r2_1.45.
Wiewel-Verschueren
S
, Mulder
AB
, Meijer
K
, Mulder
R
. Factor 11 single-nucleotide variants in women with heavy menstrual bleeding
. J Obstet Gynaecol
. 2017
;37
(7
):912
-918
.46.
O'Connell
NM
, Saunders
RE
, Lee
CA
, Perry
DJ
, Perkins
SJ
. Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling
. J Thromb Haemost
. 2005
;3
(1
):127
-138
.47.
Tiscia
GL
, Favuzzi
G
, Lupone
MR
, et al. Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship
. Hum Genome Var
. 2017
;4
:17043
.48.
Saunders
RE
, Shiltagh
N
, Gomez
K
, et al. Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency
. Thromb Haemost
. 2009
;102
(2
):287
-301
.49.
Jayandharan
G
, Shaji
RV
, Nair
SC
, Chandy
M
, Srivastava
A
. Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency (Phe349Val)
. J Thromb Haemost
. 2005
;3
(4
):808
-811
.50.
Castaman
G
, Giacomelli
SH
, Habart
D
, Asselta
R
, Duga
S
, Rodeghiero
F
. Factor XI gene mutations in factor XI deficient patients of the Czech Republic
. Am J Hematol
. 2008
;83
(12
):916
-919
.51.
Ponczek
MB
. High molecular weight kininogen: a review of the structural literature
. Int J Mol Sci
. 2021
;22
(24
):13370
.52.
Singh
PK
, Chen
ZL
, Horn
K
, Norris
EH
. Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms
. Res Pract Thromb Haemost
. 2022
;6
(7
):e12815
.53.
Chen
ZL
, Singh
PK
, Horn
K
, et al. Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo
. Blood Adv
. 2023
;7
(7
):1156
-1167
.54.
Ivanov
I
, Shakhawat
R
, Sun
MF
, et al. Nucleic acids as cofactors for factor XI and prekallikrein activation: different roles for high-molecular-weight kininogen
. Thromb Haemost
. 2017
;117
(4
):671
-681
.55.
Silasi
R
, Keshari
RS
, Lupu
C
, et al. Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death
. Blood Adv
. 2019
;3
(4
):658
-669
.56.
Leung
PY
, Hurst
S
, Berny-Lang
MA
, et al. Inhibition of factor XII-mediated activation of factor XI provides protection against experimental acute ischemic stroke in mice
. Transl Stroke Res
. 2012
;3
(3
):381
-389
.57.
Lorentz
CU
, Verbout
NG
, Cao
Z
, et al. Factor XI contributes to myocardial ischemia-reperfusion injury in mice
. Blood Adv
. 2018
;2
(2
):85
-88
.58.
Ngo
ATP
, Jordan
KR
, Mueller
PA
, et al. Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice
. J Thromb Haemost
. 2021
;19
(4
):1001
-1017
.59.
Kohs
TCL
, Fallon
ME
, Oseas
EC
, et al. Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice
. Metab Brain Dis
. 2023
;38
(7
):2383
-2391
.60.
Lorentz
CU
, Tucker
EI
, Verbout
NG
, et al. The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial
. Blood
. 2021
;138
(22
):2173
-2184
.61.
Sun
Y
, Gailani
D
. Identification of a factor IX binding site on the third apple domain of activated factor XI
. J Biol Chem
. 1996
;271
(46
):29023
-29028
.62.
Geng
Y
, Verhamme
IM
, Sun
MF
, Bajaj
SP
, Emsley
J
, Gailani
D
. Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa
. J Thromb Haemost
. 2013
;11
(7
):1374
-1384
.63.
Choi
SH
, Smith
SA
, Morrissey
JH
. Polyphosphate is a cofactor for the activation of factor XI by thrombin
. Blood
. 2011
;118
(26
):6963
-6970
.64.
Geng
Y
, Verhamme
IM
, Smith
SA
, et al. Factor XI anion-binding sites are required for productive interactions with polyphosphate
. J Thromb Haemost
. 2013
;11
(11
):2020
-2028
.65.
Puy
C
, Tucker
EI
, Matafonov
A
, et al. Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor
. Blood
. 2015
;125
(9
):1488
-1496
.66.
Tucker
EI
, Marzec
UM
, White
TC
, et al. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
. Blood
. 2009
;113
(4
):936
-944
.67.
Blenner
MA
, Dong
X
, Springer
TA
. Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib
. J Biol Chem
. 2014
;289
(9
):5565
-5579
.68.
Berny
MA
, White
TC
, Tucker
EI
, et al. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist
. Arterioscler Thromb Vasc Biol
. 2008
;28
(2
):329
-334
.69.
Reitsma
SE
, Pang
J
, Raghunathan
V
, et al. Role of platelets in regulating activated coagulation factor XI activity
. Am J Physiol Cell Physiol
. 2021
;320
(3
):C365
-C374
.70.
Kossmann
S
, Lagrange
J
, Jackel
S
, et al. Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension
. Sci Transl Med
. 2017
;9
(375
):eaah4923
.71.
Kohs
TC
, Vu
HH
, Jordan
KR
, et al. Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia
. Res Pract Thromb Haemost
. 2023
;8
(1
). 102276.72.
Cheng
Q
, Sun
MF
, Kravtsov
DV
, Aktimur
A
, Gailani
D
. Factor XI apple domains and protein dimerization
. J Thromb Haemost
. 2003
;1
(11
):2340
-2347
.73.
van Montfoort
ML
, Knaup
VL
, Marquart
JA
, et al. Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model
. Thromb Haemost
. 2013
;110
(5
):1065
-1073
.74.
Al-Horani
RA
, Desai
UR
. Factor XIa inhibitors: a review of the patent literature
. Expert Opin Ther Pat
. 2016
;26
(3
):323
-345
.75.
Wolberg
AS
, Morris
DP
, Stafford
DW
. Factor IX activation by factor XIa proceeds without release of a free intermediate
. Biochemistry
. 1997
;36
(14
):4074
-4079
.76.
Gailani
D
, Geng
Y
, Verhamme
I
, et al. The mechanism underlying activation of factor IX by factor XIa
. Thromb Res
. 2014
;133
(suppl 1
):S48
-51
.77.
Whelihan
MF
, Orfeo
T
, Gissel
MT
, Mann
KG
. Coagulation procofactor activation by factor XIa
. J Thromb Haemost
. 2010
;8
(7
):1532
-1539
.78.
Puy
C
, Tucker
EI
, Ivanov
IS
, et al. Platelet-derived short-chain polyphosphates enhance the inactivation of tissue factor pathway inhibitor by activated coagulation factor XI
. PLoS One
. 2016
;11
(10
):e0165172
.79.
Garland
KS
, Reitsma
SE
, Shirai
T
, et al. Removal of the C-terminal domains of ADAMTS13 by activated coagulation factor XI induces platelet adhesion on endothelial cells under flow conditions
. Front Med
. 2017
;4
:232
.80.
Bane
CE
, Ivanov
I
, Matafonov
A
, et al. Factor XI deficiency alters the cytokine response and activation of contact proteases during polymicrobial sepsis in mice
. PLoS One
. 2016
;11
(4
):e0152968
.81.
Scott
CF
, Silver
LD
, Purdon
AD
, Colman
RW
. Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function
. J Biol Chem
. 1985
;260
(19
):10856
-10863
.82.
Puy
C
, Pang
J
, Reitsma
SE
, et al. Cross-talk between the complement pathway and the contact activation system of coagulation: activated factor XI neutralizes complement factor H
. J Immunol
. 2021
;206
(8
):1784
-1792
.83.
Shi
T
, Giannakopoulos
B
, Iverson
GM
, Cockerill
KA
, Linnik
MD
, Krilis
SA
. Domain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318
. J Biol Chem
. 2005
;280
(2
):907
-912
.84.
Heal
SL
, Hardy
LJ
, Wilson
CL
, et al. Novel interaction of properdin and coagulation factor XI: crosstalk between complement and coagulation
. Res Pract Thromb Haemost
. 2022
;6
(4
):e12715
.85.
Ge
X
, Yamaguchi
Y
, Zhao
L
, et al. Prochemerin cleavage by factor XIa links coagulation and inflammation
. Blood
. 2018
;131
(3
):353
-364
.86.
Peek
M
, Moran
P
, Mendoza
N
, Wickramasinghe
D
, Kirchhofer
D
. Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa
. J Biol Chem
. 2002
;277
(49
):47804
-47809
.87.
Knauer
DJ
, Majumdar
D
, Fong
PC
, Knauer
MF
. SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor
. J Biol Chem
. 2000
;275
(48
):37340
-37346
.88.
Yi
BA
, Freedholm
D
, Widener
N
, et al. Pharmacokinetics and pharmacodynamics of abelacimab (MAA868), a novel dual inhibitor of factor XI and factor XIa
. J Thromb Haemost
. 2022
;20
(2
):307
-315
.89.
Verhamme
P
, Yi
BA
, Segers
A
, et al. Abelacimab for prevention of venous thromboembolism
. N Engl J Med
. 2021
;385
(7
):609
-617
.90.
Schaefer
M
, Buchmueller
A
, Dittmer
F
, Straßburger
J
, Wilmen
A
. Allosteric inhibition as a new mode of action for BAY 1213790, a neutralizing antibody targeting the activated form of coagulation factor XI
. J Mol Biol
. 2019
;431
(24
):4817
-4833
.91.
Zilberman-Rudenko
J
, Itakura
A
, Wiesenekker
CP
, et al. Coagulation factor XI promotes distal platelet activation and single platelet consumption in the bloodstream under shear flow
. Arterioscler Thromb Vasc Biol
. 2016
;36
(3
):510
-517
.92.
Piccini
JP
, Caso
V
, Connolly
SJ
, et al. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
. Lancet
. 2022
;399
(10333
):1383
-1390
.93.
Rao
SV
, Kirsch
B
, Bhatt
DL
, et al. A multicenter, phase 2, randomized, placebo-controlled, double-blind, parallel-group, dose-finding trial of the oral factor XIa inhibitor asundexian to prevent adverse cardiovascular outcomes after acute myocardial infarction
. Circulation
. 2022
;146
(16
):1196
-1206
.94.
Cao
Y
, Wang
Y
, Zhou
Z
, et al. Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure
. Science
. 2022
;377
(6613
):1399
-1406
.95.
Gailani
D
, Schmidt
A
, Sun
MF
, Bolton-Maggs
PH
, Bajaj
SP
. A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect
. J Thromb Haemost
. 2007
;5
(4
):781
-787
.96.
Puy
C
, Rigg
RA
, McCarty
OJ
. The hemostatic role of factor XI
. Thromb Res
. 2016
;141
(suppl 2
):S8
-S11
.97.
Zucker
M
, Seligsohn
U
, Salomon
O
, Wolberg
AS
. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency
. J Thromb Haemost
. 2014
;12
(7
):1121
-1130
.© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2024
You do not currently have access to this content.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal